Genesis Therapeutics Funding: $300M Raised, Series B (2023)
Genesis Therapeutics is based in South San Francisco, CA. It has raised $300M in total funding. Latest round: Series B.
Genesis Therapeutics funding overview
Genesis Therapeutics is based in South San Francisco, CA. Genesis Therapeutics has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in October 2023. The round record for Genesis Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Andreessen Horowitz, NVIDIA's venture arm. 2 distinct backers are named across the disclosed rounds.
Genesis Therapeutics at a glance
Total raised
$300M
Latest round
Series B
Latest round date
October 2023
Headquarters
South San Francisco, CA
Notable investors
Andreessen Horowitz, NVIDIA's venture arm
Frequently asked about Genesis Therapeutics funding
How much has Genesis Therapeutics raised?
Genesis Therapeutics has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Genesis Therapeutics?
Andreessen Horowitz, NVIDIA's venture arm are named among the investors backing Genesis Therapeutics.
What was the latest Genesis Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2023.
Where is Genesis Therapeutics based?
Genesis Therapeutics is based in South San Francisco, CA.
When did Genesis Therapeutics last raise?
The last disclosed Genesis Therapeutics round closed in October 2023 at Series B.
We update the Genesis Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in South San Francisco and their backers are listed below.
